carbamide 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 4264 | 57-13-6 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids.
|
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Oct. 5, 1966 | FDA | HOSPIRA |
FDA Adverse Event Reporting System (Female)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Palmar-plantar erythrodysaesthesia syndrome | 90.55 | 23.47 | 31 | 1563 | 20067 | 50583463 |
| Platelet count decreased | 25.86 | 23.47 | 23 | 1571 | 100703 | 50502827 |
| Hypertension | 25.12 | 23.47 | 32 | 1562 | 211171 | 50392359 |
FDA Adverse Event Reporting System (Male)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Palmar-plantar erythrodysaesthesia syndrome | 121.16 | 24.61 | 41 | 1584 | 14718 | 29558184 |
| Decreased appetite | 41.22 | 24.61 | 45 | 1580 | 145297 | 29427605 |
| Hepatic encephalopathy | 34.49 | 24.61 | 16 | 1609 | 13019 | 29559883 |
| Hepatocellular carcinoma | 29.65 | 24.61 | 12 | 1613 | 7026 | 29565876 |
FDA Adverse Event Reporting System (Geriatric)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Palmar-plantar erythrodysaesthesia syndrome | 211.99 | 20.68 | 72 | 3146 | 28747 | 64466767 |
| Decreased appetite | 46.01 | 20.68 | 63 | 3155 | 281226 | 64214288 |
| Platelet count decreased | 44.46 | 20.68 | 48 | 3170 | 167663 | 64327851 |
| Hepatic function abnormal | 42.64 | 20.68 | 31 | 3187 | 64282 | 64431232 |
| Hepatic encephalopathy | 34.23 | 20.68 | 18 | 3200 | 21048 | 64474466 |
| Hypertension | 33.52 | 20.68 | 52 | 3166 | 259209 | 64236305 |
| Diarrhoea | 30.73 | 20.68 | 92 | 3126 | 722612 | 63772902 |
| Hepatocellular carcinoma | 28.69 | 20.68 | 12 | 3206 | 8391 | 64487123 |
| Colon cancer | 26.90 | 20.68 | 13 | 3205 | 12726 | 64482788 |
| Dermatitis exfoliative | 26.28 | 20.68 | 12 | 3206 | 10340 | 64485174 |
| Enterocolitis | 24.58 | 20.68 | 12 | 3206 | 12006 | 64483508 |
| Blood bilirubin increased | 21.74 | 20.68 | 20 | 3198 | 57533 | 64437981 |
| Malignant neoplasm progression | 21.03 | 20.68 | 27 | 3191 | 112844 | 64382670 |
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | B05BC02 | BLOOD AND BLOOD FORMING ORGANS BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS I.V. SOLUTIONS Solutions producing osmotic diuresis |
| ATC | D02AE01 | DERMATOLOGICALS EMOLLIENTS AND PROTECTIVES EMOLLIENTS AND PROTECTIVES Carbamide products |
| ATC | D02AE51 | DERMATOLOGICALS EMOLLIENTS AND PROTECTIVES EMOLLIENTS AND PROTECTIVES Carbamide products |
| CHEBI has role | CHEBI:33287 | fertilizers |
| CHEBI has role | CHEBI:64577 | dough improvers |
| CHEBI has role | CHEBI:75771 | Mus musculus metabolites |
| CHEBI has role | CHEBI:75772 | S. cerevisiae metabolites |
| CHEBI has role | CHEBI:76971 | Escherichia coli metabolites |
| CHEBI has role | CHEBI:77746 | Homo sapiens metabolite |
| CHEBI has role | CHEBI:83056 | Daphnia magna metabolites |
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Impacted cerumen | indication | 18070006 | |
| Atopic dermatitis | indication | 24079001 | DOID:3310 |
| Contact dermatitis | indication | 40275004 | DOID:2773 |
| Seborrheic dermatitis | indication | 50563003 | DOID:8741 |
| Pityriasis versicolor | indication | 56454009 | DOID:9060 |
| Pityriasis simplex | indication | 200767005 | |
| Eruption of skin | indication | 271807003 | DOID:0050486 |
| Acne vulgaris | off-label use | 88616000 | |
| Hyperkeratosis | off-label use | 396228006 | |
| Rosacea | off-label use | 398909004 | DOID:8881 |
| Injury of ear | contraindication | 2999009 | |
| Otalgia | contraindication | 16001004 | |
| Chronic purulent otitis media | contraindication | 38394007 | DOID:14247 |
| Perforation of tympanic membrane | contraindication | 60442001 | |
| Procedure on ear | contraindication | 118891001 | |
| Infection of ear | contraindication | 129127001 | |
| Irritation of ear | contraindication | 162360008 | |
| Itching of ear | contraindication | 699392007 | |
| Ear Redness | contraindication |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 11.96 | acidic |
| pKa2 | 13.39 | acidic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Olfactory receptor 51E2 | GPCR | EC50 | 7.64 | CHEMBL |
External reference:
| ID | Source |
|---|---|
| 4018430 | VUID |
| N0000146756 | NUI |
| D00023 | KEGG_DRUG |
| 4018430 | VANDF |
| C0041942 | UMLSCUI |
| CHEBI:16199 | CHEBI |
| URE | PDB_CHEM_ID |
| CHEMBL985 | ChEMBL_ID |
| DB03904 | DRUGBANK_ID |
| 4539 | IUPHAR_LIGAND_ID |
| 1176 | PUBCHEM_CID |
| 11002 | RXNORM |
| 5656 | MMSL |
| 9476 | MMSL |
| d04207 | MMSL |
| 002015 | NDDF |
| 002273 | NDDF |
| 16858004 | SNOMEDCT_US |
| 387092000 | SNOMEDCT_US |
| D014508 | MESH_DESCRIPTOR_UI |
| 8W8T17847W | UNII |
Pharmaceutical products:
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| Urea Cream 40% | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0904-7167 | CREAM | 400 mg | TOPICAL | unapproved drug other | 16 sections |
| Urea Cream 40% | HUMAN PRESCRIPTION DRUG LABEL | 1 | 16477-340 | CREAM | 400 mg | TOPICAL | unapproved drug other | 15 sections |
| Urea Cream 41% | HUMAN PRESCRIPTION DRUG LABEL | 1 | 16477-341 | CREAM | 410 mg | TOPICAL | unapproved drug other | 15 sections |
| UREA | HUMAN PRESCRIPTION DRUG LABEL | 1 | 42192-101 | EMULSION | 50 g | TOPICAL | unapproved drug other | 14 sections |
| UREA HYDRATING TOPICAL | HUMAN PRESCRIPTION DRUG LABEL | 1 | 42192-115 | AEROSOL, FOAM | 35 g | TOPICAL | unapproved drug other | 14 sections |
| UREA | HUMAN PRESCRIPTION DRUG LABEL | 1 | 42291-849 | CREAM | 40 g | TOPICAL | unapproved drug other | 13 sections |
| UREA | HUMAN PRESCRIPTION DRUG LABEL | 1 | 42291-849 | CREAM | 40 g | TOPICAL | unapproved drug other | 13 sections |
| YouGreen F | HUMAN OTC DRUG LABEL | 1 | 42361-043 | OINTMENT | 7.50 g | TOPICAL | unapproved drug other | 9 sections |
| CEM-Urea | HUMAN PRESCRIPTION DRUG LABEL | 1 | 42546-100 | SOLUTION | 0.45 mL | TOPICAL | unapproved drug other | 13 sections |
| UREA | HUMAN PRESCRIPTION DRUG LABEL | 1 | 42792-101 | CREAM | 390 mg | TOPICAL | unapproved drug other | 9 sections |
| UREA | HUMAN PRESCRIPTION DRUG LABEL | 1 | 42808-202 | CREAM | 450 mg | TOPICAL | unapproved drug other | 15 sections |
| Urea | HUMAN PRESCRIPTION DRUG LABEL | 1 | 42808-204 | GEL | 450 mg | TOPICAL | unapproved drug other | 16 sections |
| UREA | HUMAN PRESCRIPTION DRUG LABEL | 1 | 44523-617 | CREAM | 400 mg | TOPICAL | unapproved drug other | 12 sections |
| Urea 47% Cream | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50096-501 | CREAM | 470 mg | TOPICAL | unapproved drug other | 11 sections |
| UREA | HUMAN PRESCRIPTION DRUG LABEL | 1 | 52187-549 | CREAM | 470 mg | TOPICAL | unapproved drug other | 11 sections |
| UREA | HUMAN PRESCRIPTION DRUG LABEL | 1 | 54295-308 | CREAM | 40 g | TOPICAL | unapproved drug other | 12 sections |
| UREA | HUMAN PRESCRIPTION DRUG LABEL | 1 | 54295-311 | CREAM | 39 g | TOPICAL | unapproved drug other | 12 sections |
| UREA | HUMAN PRESCRIPTION DRUG LABEL | 1 | 54295-312 | LOTION | 40 g | TOPICAL | unapproved drug other | 12 sections |
| Urea 40 Percent | HUMAN PRESCRIPTION DRUG LABEL | 1 | 58657-487 | CREAM | 400 mg | TOPICAL | unapproved drug other | 16 sections |
| Urea 41% | HUMAN PRESCRIPTION DRUG LABEL | 1 | 59088-489 | CREAM | 410 mg | TOPICAL | unapproved drug other | 16 sections |
| Uremol | HUMAN OTC DRUG LABEL | 1 | 61344-452 | LOTION | 100 mg | TOPICAL | unapproved drug other | 8 sections |
| Uremol 20% cream | HUMAN OTC DRUG LABEL | 1 | 61344-455 | CREAM | 200 mg | TOPICAL | unapproved drug other | 7 sections |
| Urea 41 Percent | HUMAN PRESCRIPTION DRUG LABEL | 1 | 63629-1150 | CREAM | 410 mg | TOPICAL | unapproved drug other | 17 sections |
| UREA | HUMAN PRESCRIPTION DRUG LABEL | 1 | 63629-2036 | CREAM | 39 g | TOPICAL | unapproved drug other | 13 sections |
| UREA | HUMAN PRESCRIPTION DRUG LABEL | 1 | 63629-2036 | CREAM | 39 g | TOPICAL | unapproved drug other | 13 sections |
| UREA | HUMAN PRESCRIPTION DRUG LABEL | 1 | 63629-2037 | CREAM | 40 g | TOPICAL | unapproved drug other | 13 sections |
| UREA | HUMAN PRESCRIPTION DRUG LABEL | 1 | 63629-2037 | CREAM | 40 g | TOPICAL | unapproved drug other | 13 sections |
| UREA | HUMAN PRESCRIPTION DRUG LABEL | 1 | 63629-2038 | CREAM | 40 g | TOPICAL | unapproved drug other | 13 sections |
| UREA | HUMAN PRESCRIPTION DRUG LABEL | 1 | 63629-2038 | CREAM | 40 g | TOPICAL | unapproved drug other | 13 sections |
| UREA | HUMAN PRESCRIPTION DRUG LABEL | 1 | 63629-2039 | CREAM | 40 g | TOPICAL | unapproved drug other | 13 sections |